Circulating Epstein-Barr virus-encoded micro-RNAs as potential biomarkers for nasal natural killer/T-cell lymphoma (Q40552301)

21 September 2017

Circulating Epstein-Barr virus-encoded micro-RNAs as potential biomarkers for nasal natural killer/T-cell lymphoma (English)

1 reference

21 September 2017

0 references

0 references

Yuki Komabayashi

1

1 reference

21 September 2017

Kan Kishibe

2

1 reference

21 September 2017

Toshihiro Nagato

3

1 reference

21 September 2017

Seigo Ueda

4

1 reference

21 September 2017

Miki Takahara

5

1 reference

21 September 2017

Yasuaki Harabuchi

6

1 reference

21 September 2017

6 October 2016

1 reference

21 September 2017

Hematological Oncology

1 reference

Characterization of novel natural killer (NK)-cell and gammadelta T-cell lines established from primary lesions of nasal T/NK-cell lymphomas associated with the Epstein-Barr virus

21 September 2017

1 reference

Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma

21 January 2018

1 reference

Clonality, expression and methylation patterns of the Epstein-Barr virus genomes in lethal midline granulomas classified as peripheral angiocentric T cell lymphomas

21 January 2018

1 reference

Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type

21 January 2018

1 reference

CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma

21 January 2018

1 reference

Production of interferon-{gamma}-inducible protein-10 and its role as an autocrine invasion factor in nasal natural killer/T-cell lymphoma cells

21 January 2018

1 reference

Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients

21 January 2018

1 reference

Soluble ICAM-1 secretion and its functional role as an autocrine growth factor in nasal NK/T cell lymphoma cells

21 January 2018

1 reference

Downregulation of miR-15a due to LMP1 promotes cell proliferation and predicts poor prognosis in nasal NK/T-cell lymphoma

21 January 2018

1 reference

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

Clinical relevance of circulating cell-free microRNAs in cancer

21 January 2018

1 reference

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

Circulating microRNAs in hematological diseases: principles, challenges, and perspectives

21 January 2018

1 reference

Systemic mirnas as potential biomarkers for malignancy

21 January 2018

1 reference

Identification of virus-encoded microRNAs

21 January 2018

1 reference

Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs.

21 January 2018

1 reference

Plasma viral microRNA profiles reveal potential biomarkers for chronic active Epstein-Barr virus infection.

21 January 2018

1 reference

Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment.

21 January 2018

1 reference

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

21 January 2018

1 reference

Characterization of Epstein-Barr virus (EBV)-infected natural killer (NK) cell proliferation in patients with severe mosquito allergy; establishment of an IL-2-dependent NK-like cell line

21 January 2018

1 reference

A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation

21 January 2018

1 reference

Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies

21 January 2018

1 reference

Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells.

21 January 2018

1 reference

Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR).

21 January 2018

1 reference

Diagnostic and prognostic value of circulating miR-221 for extranodal natural killer/T-cell lymphoma

21 January 2018

1 reference

The microRNAs of Epstein-Barr Virus are expressed at dramatically differing levels among cell lines

21 January 2018

1 reference

Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas

21 January 2018

1 reference

MicroRNA profiling of Epstein-Barr virus-associated NK/T-cell lymphomas by deep sequencing

21 January 2018

1 reference

Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5.

21 January 2018

1 reference

EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN.

21 January 2018

1 reference

Epstein-Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma

21 January 2018

1 reference

Secretory mechanisms and intercellular transfer of microRNAs in living cells

21 January 2018

1 reference

Selective release of microRNA species from normal and malignant mammary epithelial cells

21 January 2018

1 reference

Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Clinical usefulness of serum EBV DNA levels of BamHI W and LMP1 for Nasal NK/T-cell lymphoma

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

0 references

1 reference